Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains

Journal of Investigative Dermatology

Volumn 128, Issue 11, 2008, Pages 2655-2664

  Jappe, Uta ^a,c   Heuck, Dagmar ^b   Strommenger, Birgit ^b   Wendt, Constanze ^a   Werner, Guido ^b   Altmann, Doris ^b   Witte, Wolfgang ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MOXIFLOXACIN; OXACILLIN; OXYTETRACYCLINE; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; PSEUDOMONIC ACID;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; DERMATOLOGY; FAR 1 GENE; FEMALE; GENE; HUMAN; LEG ULCER; LUKF GENE; LUKS GENE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OUTPATIENT DEPARTMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN INFECTION; SKIN INFLAMMATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; EXOTOXINS; FEMALE; FUSIDIC ACID; GERMANY; HUMANS; LEUKOCIDINS; MALE; METHICILLIN; METHICILLIN RESISTANCE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 53949100238     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.133     Document Type: Article

References (61)

1. Al-Tawfiq JA, Aldaabil RA (2005) Community-acquired MRSA bacteremic necrotizing pneumonia in a patient with scrotal ulceration. J Infect 51:241-3
2. Bahrain M, Vasiliades M, Wolff M, Younus F (2006) Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis 38:702-7
3. Bubeck Wardenburg J, Bae T, Otto M, DeLeo FR, Schneewind O (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405-6
4. Couppie P, Cribier B, Prevost G, Grosshans E, Piemont Y (1994) Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 130:1208-9
5. Cribier B, Prevost G, Coupie P, Finck-Barbancon V, Grosshans E, Piemont Y (1992) Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 185:175-85
6. Cuny C, Pasemann B, Witte W (1999) Detection of oxacillin resistance in Staphylococcus aureus by screening tests. Eur J Clin Microbiol Infect Dis 18:834-6
7. Cuny C, Zappletal C, Langenscheidt PH, Witte W (1996) Genomic typing of Staphylococcus aureus from pyomyositis in Uganda. Med Microbiol Lett 5:124-32
8. Del Giudice P, Blanc V, Durupt F, Bes M, Martinez JP, Counillon E et al. (2006) Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 154:118-24
9. Deutsches Institut für Normung (2004) DIN 58940. Medical microbiology-susceptibility testing of pathogens to antimicrobial agents. Part 8: microdilution. General method specific requirements. In: DIN-Taschenbuch 222: Medizinische Mikrobiologie und Immunologie - Diagnostische Verfahren (DIN Deutsches Institut für Normung e.V., ed), Berlin: Beuth-Verlag, 342-53
10. Embil J, Ramotar K, Romance L, Alfa M, Conly J, Cronk S et al. (1994) Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol 15:646-51
11. Enright M, Robinson D, Randle G, Feil EJ, Grundmann H, Spratt BG (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 99:7687-92
12. Fleming SW, Brown LH, Tice SE (2006) Community-acquired methicillin-resistant Staphylococcus aureus skin infections: report of a local outbreak and implications for emergency department care. J Am Acad Nurse Pract 18:297-300
13. Fridkin SK, Hagemann JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA et al. (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436-44
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:129-40
15. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-9
16. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D et al. (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442-8
17. Helgason KO, Jones ME, Edwards G (2008) Panton-Valentine leukocidin-positive Staphylococcus aureus and foreign travel. J Clin Microbiol 46:832-3
18. Ho PL, Cheung C, Mak GC, Tse CW, Ng TK, Cheung CH et al. (2007) Molecular epidemiology and household transmission of community-associated methicillin-resistant Staphylococcus aureus in Hong Kong. Diagn Microbiol Infect Dis 57:145-51
19. Jappe U, Petzoldt D, Wendt C (2004) Methicillin-resistant Staphylococcus aureus colonization in inflammatory versus non-inflammatory skin diseases: who should be screened? Acta Derm Venereol 84:1-7
20. Koning S, van Suijlekom-Smit LWA, Nouwen JL, Verduin CM, Bernsen RMD, Oranje AP et al. (2002) Fusidic acid cream in the treatment of impetigo in general practice: double-blind randomised placebo controlled trial. BMJ 324:203-6
21. Labandeira-Rey M, Couzon F, Boisset S, Brown E, Bes M, Benito Y et al. (2007) Staphylococcus aureusPanton Valentine leukocidin causes necrotizing pneumonia. Science 315:1130-3
22. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V et al. (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128-32
23. Linde H, Wagenlehner F, Strommenger B, Drubel I, Tanzer J, Reischl U et al. (2005) Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis 24:1-5
24. Lowy FD (1998) Staphylococcus aureus infections. New Engl J Med 339:520-32
25. Lu D, Holtom P (2005) Community-acquired methicillin-resistant Staphylococcus aureus, a new player in sports medicine. Curr Sports Med Rep 4:265-70
26. Maier J, Melzl H, Reischl U, Drubel I, Witte W, Lehn N et al. (2005) Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin. Eur J Clin Microbiol Infect Dis. 24:637-9
27. McBride ME, Schaefer D, Rudolph AH, Aldama S, Wolf JE Jr (1989) Evaluation of antibacterial sensitivity testing methods for methicillin- resistant S. aureus in a dermatology outpatient population. South Med J 82:165-8
28. Millar BC, Loughrey A, Elborn JS, Moore JE (2007) Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 67:109-13
29. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS (2005) Necrotizing fasciitis caused by community-associated methicillin- resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445-53
30. Moreno F, Crisp C, Jorgenson J, Patterson J (1995) Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 21:1308-12
31. Mueller-Premru M, Strommenger B, Alikadic N, Witte W, Friedrich AW, Seme K et al. (2005) New strains of community-acquired methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin causing an outbreak of severe soft tissue infection in a football team. Eur J Clin Microbiol Infect Dis 24:848-50
32. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, Zinn CE et al. (2003) Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus of 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 41:1574-85
33. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J et al. (2003) Comparison of community- and health care associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-84
34. Nolte O, Haag H, Zimmerman A, Geiss HK (2005) Staphylococcus aureus positive for Panton-Valentine leukocidin genes but susceptible to methicillin in patients with furuncles. Eur J Clin Microbiol Infect Dis 24:477-9
35. Oliveira D, De Lencastre H (2002) Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46:2155-61
36. Osterlund A, Kahlmeter G, Bieber L, Runehagen A, Breider JM (2002) Intrafamilial spread of highly virulent Staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin. Scand J Infect Dis 34:763-4
37. Peeters KA, Mascini EM, Blok HE, Sanders CJ (2002) Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis. Ned Tijdschr Geneeskd 146:2100-1
38. Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B et al. (1995) Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 42:237-45
39. Price MF, McBride ME, Wolf JE (1998) Prevalence of methicillin-resistant Staphylococcus aureus in a dermatology outpatient population. South Med J 91:369-71
40. Ravenscroft JC, Layton AM, Eady EA, Murtagh MS, Coates P, Walker M et al. (2003) Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 148:1010-7
41. Robert Koch-Institut Wernigerode (2004a) Community acquired MRSA weltweit und in Deutschland. Epid Bull 5:33-6
42. Robert Koch-Institut Wernigerode (2004b) Zur MRSA-Situation in Deutschland im Jahr 2003. Epid Bull 42:358-61
43. Robert Koch Institut (2007) Zur MRSA-Situation in Deutschland 2005 und 2006. Epid Bull 6:41-7
44. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G et al. (2005) Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 365:1256-8
45. Said-Salim B, Mathema B, Braughton K, Davis S, Sinsimer D, Eisner W et al. (2005) Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 43:3373-9
46. Salgado CD, Farr BM, Calfee DP (2003) Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36:131-9
47. Shah M, Mohanraj M (2003) High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients. Br J Dermatol 148:1018-20
48. Strommenger B, Kehrenberg C, Kettlitz C, Cuny C, Verspohl J, Witte W et al. (2006a) Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J Antimicrob Chemother 57:461-5
49. Strommenger B, Kettlitz C, Weniger T, Harmsen D, Friedrich AW, Witte W (2006b) Assignment of Staphylococcus isolates to groups by spa typing, SmaI macro-restriction analysis, and multilocus sequence typing. J Clin Microbiol 44:2533-40
50. Turnidge J, Collignon P (1999) Resistance to fusidic acid. Int J Antimicrobial Agents 12(Suppl 2):S35-44
51. von Baum H, Schmidt C, Svoboda D, Bock-Hensley O, Wendt C (2002) Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infect Control Hosp Epidemiol 23:511-5
52. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D et al. (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194:1761-70
53. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M et al. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510-4
54. Wiese-Posselt M, Heuck D, Draeger A, Mielke M, Witte W, Ammon A et al. (2007) Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis 44:e88-95
55. Witte W, Braulke C, Cuny C, Strommenger B, Werner G, Heuck D et al. (2005) Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 24:1-5
56. Witte W, Cuny C, Halle E, Mauch H, Wagner J (1994) Methicillin resistance in an epidemic Staphylococcus aureus strain with genomic fingerprints corresponding to those. Med Microb Lett 3:388-95
57. Witte W, Cuny C, Strommenger B, Braulke C, Heuck D (2004) Emergence of a new community-acquired MRSA strain in Germany. Euro Surveill 9:1-2
58. Witte W, Richardson JF, Marples RR (1988) Complex typing of methicillin-resistant Staphylococcus aureus (MRSA). Zbl Bakt Hyg A 270:26876-82
59. Witte W, Strommenger B, Cuny C, Heuck D, Nuebel U (2007) Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrobial Chemother 60:1258-63
60. Yamasaki O, Kaneko J, Morizane S, Akiyama H, Arata J, Marita S et al. (2005) The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 40:381-5
61. Zaraket H, Otsuka T, Saito K, Dohmae S, Takano T, Higuchi W et al. (2007) Molecular characterization of methicillin-resistant Staphylococcus aureus in hospitals in Niigata, Japan: divergence and transmission. Microb Immunol 51:171-6